Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 833 of 1,261

  1. US 8637503

    Phenothiazine enantiomers as agents for the prevention of bone loss

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  2. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  3. US 8637676

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  4. US 8637538

    Methods for treatment of pruritis

    Trevi Therapeutics, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  5. US 8637540

    Compositions for deterring abuse of opioid containing dosage forms

    Acurx Pharmaceuticals, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  6. US 8637031

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  7. US 8637506

    Compositions and methods for bone formation and remodeling

    UNIVERSITY OF CONNECTICUT · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  8. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  9. US 8637009

    Thermostabilization of proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  10. US 8637675

    Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)

    The Board of Regents of the University of Texas System · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  11. US 8636997

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  12. US 8636988

    Composition for treatment of sunburned skin

    Doctor Essentials · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  13. US 8633178

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  14. US 8633277

    Methods for forming polymer-drug conjugates

    Nektar Therapeutics · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  15. US 8633177

    Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  16. US 8633189

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  17. US 8633210

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  18. US 8633034

    Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution

    The Regents of the University of Colorado · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  19. US 8633205

    Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  20. US 8633120

    Lyocell fiber

    LENZING AKTIENGESELLSCHAFT · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  21. US 8632771

    High molecular weight derivatives of vitamin K-dependent polypeptides

    The United States of America as represented by Department of Veterens Affairs · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  22. US 8632751

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Universitair Medisch Centrum Utrecht · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  23. US 8632782

    Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  24. US 8632808

    Taste-masking solid preparation of pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.